Nemera

Nemera

About Nemera

Simplify's Rating
Why Nemera is rated
B
Rated C on Competitive Edge
Rated A on Growth Potential
Rated B on Rating Differentiation

Industries

Biotechnology

Healthcare

Company Size

501-1,000

Company Stage

Acquired

Total Funding

$1.2B

Headquarters

La Verpillière, France

Founded

2014

Overview

Simplify Jobs

Simplify's Take

What believers are saying

  • Symbioze captures market share in the wearable medical device sector.
  • UniSpray benefits from increased interest in nasal drug delivery systems.
  • Milfra acquisition offers growth opportunities in the Latin American market.

What critics are saying

  • Competition in the wearable injector market could impact Nemera's market share.
  • Crowded unidose system market pressures UniSpray to differentiate.
  • Rising raw material costs may affect Nemera's profit margins.

What makes Nemera unique

  • Nemera's Symbioze targets the growing wearable medical device market.
  • UniSpray capitalizes on the expanding unidose nasal spray market.
  • Commitment to ESG practices enhances Nemera's brand reputation.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$1150M

Above

Industry Average

Funded Over

1 Rounds

Acquisition funding comparison data is currently unavailable. We're working to provide this information soon!
Acquisition Funding Comparison
Coming Soon

Benefits

Remote Work Options

Company News

Nemera
Oct 11th, 2023
Nemera extends manufacturing capabilities in North America

That's the new space Nemera has acquired to set up the next state-of-the-art manufacturing facility.

Job Match Ohio
Sep 15th, 2023
Printer Operator- Off Shift

In May of 2014, Rexam sold the plastics business and the Berlin Plant was acquired by Nemera, naming the prescription products business as Centor Inc.

The Real Deal
Jul 25th, 2023
Panattoni gets $26M for Vernon Hills industrial building

French medical device manufacturer Nemera is expanding its industrial footprint in suburban Chicago.

Nemera
Mar 10th, 2023
Nemera reinforces commitment to sustainability with first integrated ESG report

Nemera France SAS is thrilled to announce the publication of its first integrated ESG report.

Nemera
Nov 23rd, 2021
Nemera launched Symbioze on Oct 23rd 21'.

In response, Nemera has recently introduced its new wearable injector device - Symbioze - whose innovative concept had been presented at Pharmapack Europe and CPhI Worldwide.

Recently Posted Jobs

Sign up to get curated job recommendations

Automation Engineering Technician

Wheeling, IL, USA

Business Development Manager - Drug Delivery Device

Wheeling, IL, USA

Quality Engineer - Capital Equipment Validation

Wheeling, IL, USA

See All Jobs

Nemera is Hiring for 31 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Nemera's jobs every few hours, so check again soon! Browse all jobs →

Business Development Manager - Drug Delivery Device

Wheeling, IL, USA

Quality Engineer - Capital Equipment Validation

Wheeling, IL, USA

See All Jobs

Nemera is Hiring for 31 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Nemera's jobs every few hours, so check again soon! Browse all jobs →